Glenn Markov

Glenn Markov

Y Combinator Logo Batch: S18

Achievements

  • Graduated from Arizona State University with undergraduate research experience
  • Earned a PhD in Genetics from Stanford University, working under Helen Blau on telomeres and epigenetics
  • Conducted postdoctoral research at Stanford School of Medicine focused on cellular reprogramming and aging science
  • Fellowship at Smithsonian Tropical Research Institute, deepening biological knowledge
  • Co-founded Rejuvenation Technologies in 2016, aiming to extend telomeres and fight age-related diseases
  • Participated in Y Combinator's Summer 2018 batch as COO of biotech startup

Can't sleep on Glenn Markov

Yo, have you heard of Glenn Markov? Dude’s a straight-up biotech boss. He’s one of those guys who jumped into the deep end early and just crushed it. So, he’s from YC’s S18 batch, which is already a big deal, right? But what really makes him stand out is his process, this guy’s been all about genetics and aging science for over a decade.

Started out at Arizona State, just your typical undergrad, then went all the way to Stanford for his PhD in Genetics. And not just any PhD, he was working in Helen Blau’s lab, doing some new stuff on telomeres and epigenetics. That’s the stuff that’s basically the fountain of youth, or at least the closest thing we got. His research focused on cellular reprogramming and extending telomeres, which are the end caps of your chromosomes that get shorter as you age. Basically, he’s been chasing the holy grail of aging tech for a long time.

After Stanford, he stuck around as a postdoc at the med school, digging even deeper into cellular reprogramming. Dude’s been in the trenches of biotech R&D for years, building real skills in translating science into actual therapies. He’s also done a short stint at the Smithsonian Tropical Research Institute, no biggie, just soaking in more knowledge about biology and nature. All this adds up to someone who’s not just geeky about genes but is genuinely passionate about extending human healthspan.

Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.

Talk to her

In 2016, Glenn co-founded Rejuvenation Technologies. The goal? Using mRNA tech to extend telomeres and tackle age-related diseases. Think about it, this isn’t just some startup trying to get rich quick. It’s about rewriting the rules of aging. And he’s been leading the charge as COO, making sure the science hits the market.

His background screams motivation. Here’s a guy who’s been deep in the science trenches and then decided, “Yeah, I can build something that actually changes lives.” That jump from academic research to founding a biotech startup? That’s the real deal. It’s not just about theory for him, he’s all in on making it real, expandable, and accessible.

So, in a nutshell, Glenn Markov is this brilliant scientist turned biotech entrepreneur who’s been chasing the aging problem for over a decade. His work is rooted in real science, telomeres, epigenetics, cellular reprogramming, and now he’s turning that into the future of health tech. No bullshit, just a guy who’s going all-in on extending human life and crushing it along the way.

Founder ID: 105965

Industries

Share your thoughts about Glenn Markov

Have you worked with this founder? Know additional information? Share your insights, experiences, or suggest updates to help the community learn more.

Select your comment type:

Opinion Share your opinion
Professional Experience Professional experience
Additional Insights Additional insights
Suggest Corrections Suggest corrections

If something is wrong about Glenn Markov, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)

Your email address will not be published. Help us build a comprehensive founder database.